Fresita Proteins Share Price Today

Fresita Proteins files LOF for ₹89.76 crore rights issue; promoters to forgo

Fresita Proteins filed Letter of Offer for ₹89.76 crore rights issue on Oct 29, 2026. Issue price set at ₹120 per share with a record date of Oct 30, 2026. Promoters holding 80.66% stake will forgo rights entitlement to meet MPS norms. Proceeds to fund investments in Fresita Food and Urja Protein subsidiaries.

Fresita Proteins shareholders approve ₹1,000 crore borrowing limit

Shareholders unanimously approved borrowing powers up to ₹1,000 crore. Loans, guarantees, and investments up to ₹1,000 crore authorized under Section 186. Mr. Shivam Gunvantray Zaladi re-appointed as director after retiring by rotation. M/s. A H Mandaliya & Associates appointed as new Statutory Auditors. All five resolutions passed with 100% votes in favour from 12 participating members.

Sarda Proteins to consider fund raising via equity or bonds

Sarda Proteins Limited scheduled a board meeting for August 05, 2026, to consider raising funds through equity shares, convertible bonds, or other securities. The proposal covers rights issues, private placements, and QIPs under SEBI ICDR Regulations. Managing Director Shirish Dhirajlal Savaliya signed the disclosure filed with BSE.

Sarda Proteins shareholders approve name change to Fresita Proteins

Sarda Proteins Limited shareholders approved a name change to Fresita Proteins Limited and an increase in authorized share capital to ₹100 crore at an EGM on July 30, 2026. The meeting also regularized several director appointments and appointed statutory auditors for a five-year term starting April 1, 2026.

Sarda Proteins board approves name change subject to MCA approval

Sarda Proteins Limited's board approved changing its name subject to Ministry of Corporate Affairs approval, necessitating changes to its Memorandum and Articles of Association. The decision was made in a meeting on July 4, 2026, and disclosed via a revised filing to BSE under Regulation 30 of SEBI Listing Regulations.

Sarda Proteins seeks auditor appointment, director regularization at EGM

Sarda Proteins has issued an addendum to its EGM notice scheduled for July 30, 2026, adding three items for shareholder approval. The company seeks to appoint M/s A H Mandaliya & Associates as statutory auditor to fill a casual vacancy and for a subsequent five-year term from FY27 to FY31. Additionally, it proposes regularizing Ms. Minal Surendra Jain, appointed as an additional director on July 15, 2026, as a woman independent director for a five-year term.